Sljedeći

Auto Play

MARS: mutation-adjusted risk score for advanced systemic mastocytosis

1 Pogledi • 07/09/23
Udio
Ugraditi
administrator
administrator
Pretplatnici
0

Andreas Reiter, MD, University Medical Centre, Mannheim, Germany, discusses how a mutation-adjusted risk score (MARS) may improve treatment stratification for advanced systemic mastocytosis (AdvSM). This interview took place at the Myeloproliferative Neoplasms Advances Day 2019 in London, UK.

Prikaži više
0 Komentari sort Poredaj po
Komentari na Facebooku

Sljedeći

Auto Play